Sana Biotechnology Valuation
| SANA Stock | USD 2.31 0.05 2.21% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Sana Biotechnology has a current Real Value of $4.07 per share. The regular price of the company is $2.31. Our model measures the value of Sana Biotechnology from inspecting the company fundamentals such as Return On Equity of -0.99, shares outstanding of 225.02 M, and Shares Owned By Institutions of 93.69 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Sana Biotechnology's valuation include:
Undervalued
Today
Please note that Sana Biotechnology's price fluctuation is extremely dangerous at this time. Calculation of the real value of Sana Biotechnology is based on 3 months time horizon. Increasing Sana Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sana Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sana Stock. However, Sana Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.31 | Real 4.07 | Target 9.8 | Hype 2.07 | Naive 1.8 |
The real value of Sana Stock, also known as its intrinsic value, is the underlying worth of Sana Biotechnology Company, which is reflected in its stock price. It is based on Sana Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sana Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sana Biotechnology helps investors to forecast how Sana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sana Biotechnology more accurately as focusing exclusively on Sana Biotechnology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Sana Biotechnology's intrinsic value based on its ongoing forecasts of Sana Biotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Sana Biotechnology's closest peers. If more than one evaluation category is relevant for Sana Biotechnology we suggest using both methods to arrive at a better estimate.
Sana Biotechnology Cash |
|
Sana Valuation Trend
Comparing Sana Biotechnology's enterprise value against its market capitalization is a good way to estimate the value of Sana Biotechnology uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Sana Biotechnology Total Value Analysis
Sana Biotechnology is at this time estimated to have valuation of 468.26 M with market capitalization of 508.56 M, debt of 94.2 M, and cash on hands of 484.8 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Sana Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
468.26 M | 508.56 M | 94.2 M | 484.8 M |
Sana Biotechnology Asset Utilization
One of the ways to look at asset utilization of Sana is to check how much profit was generated for every dollar of assets it reports. Sana Biotechnology has a negative utilization of assets of -0.32 %, losing $0.003182 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Sana Biotechnology shows how discouraging it operates for each dollar spent on its assets.Sana Biotechnology Ownership Allocation
Sana Biotechnology shows a total of 225.02 Million outstanding shares. The majority of Sana Biotechnology outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Sana Biotechnology to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Sana Biotechnology. Please pay attention to any change in the institutional holdings of Sana Biotechnology as this could imply that something significant has changed or is about to change at the company. Also note that roughly five million one hundred eight thousand sixty-seven invesors are currently shorting Sana Biotechnology expressing very little confidence in its future performance.Sana Biotechnology Profitability Analysis
Net Loss for the year was (266.76 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sana Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sana Biotechnology and how it compares across the competition.
About Sana Biotechnology Valuation
The stock valuation mechanism determines Sana Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sana Biotechnology. We calculate exposure to Sana Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sana Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -27.8 M | -26.4 M |
Sana Biotechnology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 230.9 M |
Sana Biotechnology Current Valuation Indicators
Valuation refers to the process of determining the present value of Sana Biotechnology and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Sana we look at many different elements of the entity such as Sana's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Sana Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Sana Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Sana Biotechnology's worth.Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |